Tanguler Tolga
CIK 0001849458
EVP, Chief Commercial OfficerDirector
Filings
22
Latest Mar 6, 2026
Issuers covered
2
Showing
22 of 22
Page 1
Track record
119 of 119 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 119 | 65% | +3.3% | +1.1% | +14.4% | -9.6% |
| 90 days | 119 | 64% | +1.8% | +7.3% | +13.7% | -25.7% |
| 180 days | 79 | 51% | -11.3% | +16.4% | +28.2% | -84.1% |
| 365 days | 53 | 26% | -25.1% | -31.7% | +26.9% | -75.7% |
Issuers
Companies where Tanguler Tolga has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals, Inc. | 20 | Mar 6, 2026 |
| LXEO | Lexeo Therapeutics, Inc. | 2 | Jun 30, 2025 |
All filings
22 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|